S100A8 and S100A9 in experimental osteoarthritis
The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA) as opposed to inflammatory arthritis. S100A8 and S100A9 protein localization were determined in antigen-induced inflammatory arthritis in mice, mouse fem...
Saved in:
Published in | Arthritis research & therapy Vol. 12; no. 1; p. R16 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
01.01.2010
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA) as opposed to inflammatory arthritis.
S100A8 and S100A9 protein localization were determined in antigen-induced inflammatory arthritis in mice, mouse femoral head cartilage explants stimulated with interleukin-1 (IL-1), and in surgically-induced OA in mice. Microarray expression profiling of all S100 proteins in cartilage was evaluated at different times after initiation of degradation in femoral head explant cultures stimulated with IL-1 and surgically-induced OA. The effect of S100A8, S100A9 or the complex on the expression of aggrecan (Acan), collagen II (Col2a1), disintegrin and metalloproteases with thrombospondin motifs (Adamts1, Adamts 4 &Adamts 5), matrix metalloproteases (Mmp1, Mmp3, Mmp13 &Mmp14) and tissue inhibitors of metalloproteinases (Timp1, Timp2 &Timp3), by primary adult ovine articular chondrocytes was determined using real time quantitative reverse transcription polymerase chain reaction (qRT-PCR).
Stimulation with IL-1 increased chondrocyte S100a8 and S100a9 mRNA and protein levels. There was increased chondrocyte mRNA expression of S100a8 and S100a9 in early but not late mouse OA. However, loss of the S100A8 staining in chondrocytes occurred as mouse OA progressed, in contrast to the positive reactivity for both S100A8 and S100A9 in chondrocytes in inflammatory arthritis in mice. Homodimeric S100A8 and S100A9, but not the heterodimeric complex, significantly upregulated chondrocyte Adamts1, Adamts4 and Adamts 5, Mmp1, Mmp3 and Mmp13 gene expression, while collagen II and aggrecan mRNAs were significantly decreased.
Chondrocyte derived S100A8 and S100A9 may have a sustained role in cartilage degradation in inflammatory arthritis. In contrast, while these proteins may have a role in initiating early cartilage degradation in OA by upregulating MMPs and aggrecanases, their reduced expression in late stages of OA suggests they do not have an ongoing role in cartilage degradation in this non-inflammatory arthropathy. |
---|---|
AbstractList | INTRODUCTION: The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA) as opposed to inflammatory arthritis. METHODS: S100A8 and S100A9 protein localization were determined in antigen-induced inflammatory arthritis in mice, mouse femoral head cartilage explants stimulated with interleukin-1 (IL-1), and in surgically-induced OA in mice. Microarray expression profiling of all S100 proteins in cartilage was evaluated at different times after initiation of degradation in femoral head explant cultures stimulated with IL-1 and surgically-induced OA. The effect of S100A8, S100A9 or the complex on the expression of aggrecan (Acan), collagen II (Col2a1), disintegrin and metalloproteases with thrombospondin motifs (Adamts1, Adamts 4 &Adamts 5), matrix metalloproteases (Mmp1, Mmp3, Mmp13 &Mmp14) and tissue inhibitors of metalloproteinases (Timp1, Timp2 &Timp3), by primary adult ovine articular chondrocytes was determined using real time quantitative reverse transcription polymerase chain reaction (qRT-PCR). RESULTS: Stimulation with IL-1 increased chondrocyte S100a8 and S100a9 mRNA and protein levels. There was increased chondrocyte mRNA expression of S100a8 and S100a9 in early but not late mouse OA. However, loss of the S100A8 staining in chondrocytes occurred as mouse OA progressed, in contrast to the positive reactivity for both S100A8 and S100A9 in chondrocytes in inflammatory arthritis in mice. Homodimeric S100A8 and S100A9, but not the heterodimeric complex, significantly upregulated chondrocyte Adamts1, Adamts4 and Adamts 5, Mmp1, Mmp3 and Mmp13 gene expression, while collagen II and aggrecan mRNAs were significantly decreased. CONCLUSIONS: Chondrocyte derived S100A8 and S100A9 may have a sustained role in cartilage degradation in inflammatory arthritis. In contrast, while these proteins may have a role in initiating early cartilage degradation in OA by upregulating MMPs and aggrecanases, their reduced expression in late stages of OA suggests they do not have an ongoing role in cartilage degradation in this non-inflammatory arthropathy. The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA) as opposed to inflammatory arthritis. S100A8 and S100A9 protein localization were determined in antigen-induced inflammatory arthritis in mice, mouse femoral head cartilage explants stimulated with interleukin-1 (IL-1), and in surgically-induced OA in mice. Microarray expression profiling of all S100 proteins in cartilage was evaluated at different times after initiation of degradation in femoral head explant cultures stimulated with IL-1 and surgically-induced OA. The effect of S100A8, S100A9 or the complex on the expression of aggrecan (Acan), collagen II (Col2a1), disintegrin and metalloproteases with thrombospondin motifs (Adamts1, Adamts 4 &Adamts 5), matrix metalloproteases (Mmp1, Mmp3, Mmp13 &Mmp14) and tissue inhibitors of metalloproteinases (Timp1, Timp2 &Timp3), by primary adult ovine articular chondrocytes was determined using real time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Stimulation with IL-1 increased chondrocyte S100a8 and S100a9 mRNA and protein levels. There was increased chondrocyte mRNA expression of S100a8 and S100a9 in early but not late mouse OA. However, loss of the S100A8 staining in chondrocytes occurred as mouse OA progressed, in contrast to the positive reactivity for both S100A8 and S100A9 in chondrocytes in inflammatory arthritis in mice. Homodimeric S100A8 and S100A9, but not the heterodimeric complex, significantly upregulated chondrocyte Adamts1, Adamts4 and Adamts 5, Mmp1, Mmp3 and Mmp13 gene expression, while collagen II and aggrecan mRNAs were significantly decreased. Chondrocyte derived S100A8 and S100A9 may have a sustained role in cartilage degradation in inflammatory arthritis. In contrast, while these proteins may have a role in initiating early cartilage degradation in OA by upregulating MMPs and aggrecanases, their reduced expression in late stages of OA suggests they do not have an ongoing role in cartilage degradation in this non-inflammatory arthropathy. Introduction The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA) as opposed to inflammatory arthritis. Methods S100A8 and S100A9 protein localization were determined in antigen-induced inflammatory arthritis in mice, mouse femoral head cartilage explants stimulated with interleukin-1 (IL-1), and in surgically-induced OA in mice. Microarray expression profiling of all S100 proteins in cartilage was evaluated at different times after initiation of degradation in femoral head explant cultures stimulated with IL-1 and surgically-induced OA. The effect of S100A8, S100A9 or the complex on the expression of aggrecan (Acan), collagen II (Col2a1), disintegrin and metalloproteases with thrombospondin motifs (Adamts1, Adamts 4 andAdamts 5), matrix metalloproteases (Mmp1, Mmp3, Mmp13 andMmp14) and tissue inhibitors of metalloproteinases (Timp1, Timp2 andTimp3), by primary adult ovine articular chondrocytes was determined using real time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Results Stimulation with IL-1 increased chondrocyte S100a8 and S100a9 mRNA and protein levels. There was increased chondrocyte mRNA expression of S100a8 and S100a9 in early but not late mouse OA. However, loss of the S100A8 staining in chondrocytes occurred as mouse OA progressed, in contrast to the positive reactivity for both S100A8 and S100A9 in chondrocytes in inflammatory arthritis in mice. Homodimeric S100A8 and S100A9, but not the heterodimeric complex, significantly upregulated chondrocyte Adamts1, Adamts4 and Adamts 5, Mmp1, Mmp3 and Mmp13 gene expression, while collagen II and aggrecan mRNAs were significantly decreased. Conclusions Chondrocyte derived S100A8 and S100A9 may have a sustained role in cartilage degradation in inflammatory arthritis. In contrast, while these proteins may have a role in initiating early cartilage degradation in OA by upregulating MMPs and aggrecanases, their reduced expression in late stages of OA suggests they do not have an ongoing role in cartilage degradation in this non-inflammatory arthropathy. INTRODUCTIONThe objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA) as opposed to inflammatory arthritis. METHODSS100A8 and S100A9 protein localization were determined in antigen-induced inflammatory arthritis in mice, mouse femoral head cartilage explants stimulated with interleukin-1 (IL-1), and in surgically-induced OA in mice. Microarray expression profiling of all S100 proteins in cartilage was evaluated at different times after initiation of degradation in femoral head explant cultures stimulated with IL-1 and surgically-induced OA. The effect of S100A8, S100A9 or the complex on the expression of aggrecan (Acan), collagen II (Col2a1), disintegrin and metalloproteases with thrombospondin motifs (Adamts1, Adamts 4 &Adamts 5), matrix metalloproteases (Mmp1, Mmp3, Mmp13 &Mmp14) and tissue inhibitors of metalloproteinases (Timp1, Timp2 &Timp3), by primary adult ovine articular chondrocytes was determined using real time quantitative reverse transcription polymerase chain reaction (qRT-PCR). RESULTSStimulation with IL-1 increased chondrocyte S100a8 and S100a9 mRNA and protein levels. There was increased chondrocyte mRNA expression of S100a8 and S100a9 in early but not late mouse OA. However, loss of the S100A8 staining in chondrocytes occurred as mouse OA progressed, in contrast to the positive reactivity for both S100A8 and S100A9 in chondrocytes in inflammatory arthritis in mice. Homodimeric S100A8 and S100A9, but not the heterodimeric complex, significantly upregulated chondrocyte Adamts1, Adamts4 and Adamts 5, Mmp1, Mmp3 and Mmp13 gene expression, while collagen II and aggrecan mRNAs were significantly decreased. CONCLUSIONSChondrocyte derived S100A8 and S100A9 may have a sustained role in cartilage degradation in inflammatory arthritis. In contrast, while these proteins may have a role in initiating early cartilage degradation in OA by upregulating MMPs and aggrecanases, their reduced expression in late stages of OA suggests they do not have an ongoing role in cartilage degradation in this non-inflammatory arthropathy. The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA) as opposed to inflammatory arthritis. S100A8 and S100A9 protein localization were determined in antigen-induced inflammatory arthritis in mice, mouse femoral head cartilage explants stimulated with interleukin-1 (IL-1), and in surgically-induced OA in mice. Microarray expression profiling of all S100 proteins in cartilage was evaluated at different times after initiation of degradation in femoral head explant cultures stimulated with IL-1 and surgically-induced OA. The effect of S100A8, S100A9 or the complex on the expression of aggrecan (Acan), collagen II (Col2a1), disintegrin and metalloproteases with thrombospondin motifs (Adamts1, Adamts 4 andAdamts 5), matrix metalloproteases (Mmp1, Mmp3, Mmp13 andMmp14) and tissue inhibitors of metalloproteinases (Timp1, Timp2 andTimp3), by primary adult ovine articular chondrocytes was determined using real time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Stimulation with IL-1 increased chondrocyte S100a8 and S100a9 mRNA and protein levels. There was increased chondrocyte mRNA expression of S100a8 and S100a9 in early but not late mouse OA. However, loss of the S100A8 staining in chondrocytes occurred as mouse OA progressed, in contrast to the positive reactivity for both S100A8 and S100A9 in chondrocytes in inflammatory arthritis in mice. Homodimeric S100A8 and S100A9, but not the heterodimeric complex, significantly upregulated chondrocyte Adamts1, Adamts4 and Adamts 5, Mmp1, Mmp3 and Mmp13 gene expression, while collagen II and aggrecan mRNAs were significantly decreased. Chondrocyte derived S100A8 and S100A9 may have a sustained role in cartilage degradation in inflammatory arthritis. In contrast, while these proteins may have a role in initiating early cartilage degradation in OA by upregulating MMPs and aggrecanases, their reduced expression in late stages of OA suggests they do not have an ongoing role in cartilage degradation in this non-inflammatory arthropathy. |
ArticleNumber | R16 |
Audience | Academic |
Author | Zreiqat, Hala Smith, Margaret M Little, Christopher B Vogl, Thomas Belluoccio, Daniele Bateman, John F Wilson, Richard Rowley, Lynn A Jones, Katie Ramaswamy, Yogambha Roth, Johannes |
AuthorAffiliation | 2 Murdoch Childrens Research Institute and the Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Flemmington Road, Parkville, Victoria 3052, Australia 1 Tissue Engineering and Biomaterials Research Unit, School of AMME J07, Faculty of Engineering, Bosch Institute, University of Sydney, Corner of Shepherd and Cleavland Street, New South Wales 2006, Australia 4 Institute of Immunology, University Hospital of Muenster, Roentgenstrasse 21, D-48149 Muenster, Germany 3 Raymond Purves Bone and Joint Research Laboratories, Kolling Institute of Medical Research, University of Sydney at Royal North Shore Hospital, Reserve Road, St. Leonards, New South Wales 2065, Australia |
AuthorAffiliation_xml | – name: 2 Murdoch Childrens Research Institute and the Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Flemmington Road, Parkville, Victoria 3052, Australia – name: 4 Institute of Immunology, University Hospital of Muenster, Roentgenstrasse 21, D-48149 Muenster, Germany – name: 1 Tissue Engineering and Biomaterials Research Unit, School of AMME J07, Faculty of Engineering, Bosch Institute, University of Sydney, Corner of Shepherd and Cleavland Street, New South Wales 2006, Australia – name: 3 Raymond Purves Bone and Joint Research Laboratories, Kolling Institute of Medical Research, University of Sydney at Royal North Shore Hospital, Reserve Road, St. Leonards, New South Wales 2065, Australia |
Author_xml | – sequence: 1 givenname: Hala surname: Zreiqat fullname: Zreiqat, Hala email: hzreiqat@usyd.edu.au organization: Tissue Engineering and Biomaterials Research Unit, School of AMME J07, Faculty of Engineering, Bosch Institute, University of Sydney, Corner of Shepherd and Cleavland Street, New South Wales 2006, Australia. hzreiqat@usyd.edu.au – sequence: 2 givenname: Daniele surname: Belluoccio fullname: Belluoccio, Daniele – sequence: 3 givenname: Margaret M surname: Smith fullname: Smith, Margaret M – sequence: 4 givenname: Richard surname: Wilson fullname: Wilson, Richard – sequence: 5 givenname: Lynn A surname: Rowley fullname: Rowley, Lynn A – sequence: 6 givenname: Katie surname: Jones fullname: Jones, Katie – sequence: 7 givenname: Yogambha surname: Ramaswamy fullname: Ramaswamy, Yogambha – sequence: 8 givenname: Thomas surname: Vogl fullname: Vogl, Thomas – sequence: 9 givenname: Johannes surname: Roth fullname: Roth, Johannes – sequence: 10 givenname: John F surname: Bateman fullname: Bateman, John F – sequence: 11 givenname: Christopher B surname: Little fullname: Little, Christopher B |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20105291$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UV9LwzAcDDJxbupHkIKgT5tJmibpizCG_2Dgg_oc0jTZIm0zk07025vZOR0oeciP_O4ux90A9BrXaABOEBwjxOml9DhHbA8cIsL4iKYU97ZzRvpgEMILhBjnmByAPoYIZpFwCOAjgnDCE9mUydeYJ7ZJ9PtSe1vrppVV4kKrnfTtwtvWhiOwb2QV9PHmHoLnm-un6d1o9nB7P53MRkVGeDsqFcdpSSBCpJAlZBqlmimVGmWQQYjh0kjDWY4V1TLLICdlQTlkmUG4MESmQ3DV6S5XRa1LFb14WYlltCX9h3DSit1NYxdi7t4E5iyjhESBvBMorPtHYHejXC26GCP3YvO5d68rHVpR26B0VclGu1UQLE1jgJDiiDzrkHNZaWEb46KWWqPFBGNEMc0Yj6jxH6h4Sl1bFZs0Nr7vEM47gvIuBK_N1jeCYl34j9PT3zFtYd8Np59C8qZR |
CitedBy_id | crossref_primary_10_2220_biomedres_35_243 crossref_primary_10_1002_art_39420 crossref_primary_10_1007_s11420_011_9250_z crossref_primary_10_1038_bonekey_2016_49 crossref_primary_10_1002_art_34453 crossref_primary_10_1186_s12900_016_0058_4 crossref_primary_10_1016_j_isci_2024_108857 crossref_primary_10_1097_BOR_0b013e328349c2b1 crossref_primary_10_1038_ng_945 crossref_primary_10_1038_boneres_2016_44 crossref_primary_10_1016_j_joca_2012_03_023 crossref_primary_10_3390_jcm12113703 crossref_primary_10_3390_biology9040065 crossref_primary_10_1016_j_joca_2019_10_010 crossref_primary_10_1002_art_38026 crossref_primary_10_1371_journal_pone_0061832 crossref_primary_10_1002_art_33495 crossref_primary_10_1302_2046_3758_116_BJR_2021_0436_R1 crossref_primary_10_1186_1477_5956_11_43 crossref_primary_10_1002_bab_2285 crossref_primary_10_1007_s11010_017_3047_4 crossref_primary_10_1038_s41598_017_00195_8 crossref_primary_10_3389_fimmu_2017_01908 crossref_primary_10_1007_s00011_021_01435_4 crossref_primary_10_3389_fphar_2022_881500 crossref_primary_10_1016_j_gene_2015_08_035 crossref_primary_10_1016_j_joca_2021_01_012 crossref_primary_10_1016_j_bbadis_2012_01_006 crossref_primary_10_1007_s11926_013_0375_6 crossref_primary_10_1038_nrrheum_2014_209 crossref_primary_10_1111_jcmm_16424 crossref_primary_10_1142_S0218957722500403 crossref_primary_10_1038_s41526_019_0063_6 crossref_primary_10_3390_ijms21113746 crossref_primary_10_1186_s13075_016_1121_z crossref_primary_10_3109_03009742_2014_918176 crossref_primary_10_1002_art_34315 crossref_primary_10_1038_nrrheum_2014_162 crossref_primary_10_3389_fimmu_2021_768244 crossref_primary_10_1002_ijc_28127 crossref_primary_10_1016_j_joca_2011_01_022 crossref_primary_10_1016_j_joca_2011_04_018 crossref_primary_10_1016_j_joca_2022_03_011 crossref_primary_10_1080_03008207_2017_1284824 crossref_primary_10_1136_annrheumdis_2014_205480 crossref_primary_10_3389_fimmu_2021_763702 crossref_primary_10_1007_s11926_013_0323_5 crossref_primary_10_1016_j_bone_2016_01_019 crossref_primary_10_1016_j_joca_2011_10_002 crossref_primary_10_1002_art_39291 crossref_primary_10_1007_s00784_020_03548_2 crossref_primary_10_3390_ijms24044120 crossref_primary_10_3390_cimb46040228 crossref_primary_10_1177_1759720X12448454 crossref_primary_10_1016_j_joca_2016_09_009 crossref_primary_10_1177_1947603520961161 crossref_primary_10_1007_s11010_017_3078_x crossref_primary_10_1124_dmd_116_069575 crossref_primary_10_1093_rheumatology_kead493 crossref_primary_10_3390_ijms13032893 |
Cites_doi | 10.1002/art.22876 10.1093/bioinformatics/bth449 10.1016/j.bbagrm.2008.02.010 10.1016/j.ajhg.2009.05.002 10.1006/prep.1998.1015 10.1074/jbc.274.13.8561 10.1189/jlb.70.1.59 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6 10.1002/art.23388 10.1186/ar2013 10.1677/jme.0.0290023 10.1002/art.22637 10.1186/1475-2840-5-6 10.4049/jimmunol.175.12.8296 10.1007/s00586-002-0434-6 10.1038/330080a0 10.1016/S1044-0305(99)00085-9 10.1038/nm1638 10.1172/JCI30765 10.1615/CritRevEukaryotGeneExpr.v15.i1.30 10.1002/art.24074 10.1182/blood-2004-02-0446 10.1002/art.20776 10.1002/art.21574 10.2353/ajpath.2009.080718 10.1089/dna.1994.13.183 10.1016/j.bbamcr.2006.08.028 10.1002/art.21022 10.4049/jimmunol.177.10.7312 10.1136/ard.2007.077800 10.1182/blood.V82.6.1875.1875 10.1016/j.jmb.2006.04.009 10.1016/S0171-2985(11)80259-7 10.1136/ard.2006.057471 10.1158/0008-5472.CAN-08-3381 10.1007/s10735-007-9117-2 10.1002/art.21215 10.1002/art.23789 10.1016/S1046-2023(03)00155-5 10.1128/MCB.23.3.1034-1043.2003 10.1186/gb-2002-3-7-research0034 10.1074/jbc.M102950200 10.1111/j.2517-6161.1995.tb02031.x |
ContentType | Journal Article |
Copyright | COPYRIGHT 2010 BioMed Central Ltd. Copyright ©2010 Zreiqat et al.; licensee BioMed Central Ltd. 2010 Zreiqat et al.; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2010 BioMed Central Ltd. – notice: Copyright ©2010 Zreiqat et al.; licensee BioMed Central Ltd. 2010 Zreiqat et al.; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1186/ar2917 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 1478-6354 |
EndPage | R16 |
ExternalDocumentID | oai_biomedcentral_com_ar2917 A221626578 10_1186_ar2917 20105291 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -5E -5G -A0 -BR .GJ 0R~ 23N 2WC 3V. 4.4 53G 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ ABUWG ACGFS ACJQM ACRMQ ADBBV ADINQ ADUKV AEGXH AENEX AFKRA AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C1A C24 C6C CCPQU CGR CS3 CUY CVF DIK E3Z EBD EBLON ECM EIF EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ IAO IHR INH INR ITC KQ8 M1P NPM O5R O5S O9- PGMZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ Z7U ZGI AAYXX CITATION 7X8 ABVAZ AFGXO AFNRJ AFPKN ZA5 5PM |
ID | FETCH-LOGICAL-b548t-dc823d40114bad07e13e7cc3fcf1f1172dfaf8792c6ea55084db68075f12bf4a3 |
IEDL.DBID | RPM |
ISSN | 1478-6354 |
IngestDate | Tue Sep 17 21:26:53 EDT 2024 Wed May 22 07:12:28 EDT 2024 Fri Oct 25 07:57:18 EDT 2024 Tue Nov 19 21:15:13 EST 2024 Tue Nov 12 23:24:12 EST 2024 Fri Nov 22 01:46:30 EST 2024 Tue Oct 15 23:38:46 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b548t-dc823d40114bad07e13e7cc3fcf1f1172dfaf8792c6ea55084db68075f12bf4a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875644/ |
PMID | 20105291 |
PQID | 733105062 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2875644 biomedcentral_primary_oai_biomedcentral_com_ar2917 proquest_miscellaneous_733105062 gale_infotracmisc_A221626578 gale_infotracacademiconefile_A221626578 crossref_primary_10_1186_ar2917 pubmed_primary_20105291 |
PublicationCentury | 2000 |
PublicationDate | 2010-01-01 |
PublicationDateYYYYMMDD | 2010-01-01 |
PublicationDate_xml | – month: 01 year: 2010 text: 2010-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Arthritis research & therapy |
PublicationTitleAlternate | Arthritis Res Ther |
PublicationYear | 2010 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | 16339570 - J Immunol. 2005 Dec 15;175(12):8296-302 19481194 - Am J Hum Genet. 2009 Jun;84(6):760-70 16447230 - Arthritis Rheum. 2006 Feb;54(2):540-50 10049680 - Protein Expr Purif. 1999 Mar;15(2):228-35 18383380 - Arthritis Rheum. 2008 Apr;58(4):1055-66 12184808 - Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 17510707 - J Clin Invest. 2007 Jun;117(6):1627-36 17636430 - J Mol Histol. 2007 Oct;38(5):381-91 15880348 - Arthritis Rheum. 2005 May;52(5):1461-72 11723110 - J Biol Chem. 2002 Feb 1;277(5):3658-65 19342367 - Am J Pathol. 2009 May;174(5):1940-8 12200227 - J Mol Endocrinol. 2002 Aug;29(1):23-39 18055478 - Ann Rheum Dis. 2008 Dec;67(12):1750-8 16573830 - Cardiovasc Diabetol. 2006;5:6 17767165 - Nat Med. 2007 Sep;13(9):1042-9 17082650 - J Immunol. 2006 Nov 15;177(10):7312-21 1490735 - Immunobiology. 1992 Nov;186(3-4):304-14 18821673 - Arthritis Rheum. 2008 Oct;58(10):3120-31 15297296 - Bioinformatics. 2004 Dec 12;20(18):3705-6 11435486 - J Leukoc Biol. 2001 Jul;70(1):59-64 15331440 - Blood. 2004 Dec 15;104(13):4260-8 15641080 - Arthritis Rheum. 2005 Jan;52(1):128-35 16052587 - Arthritis Rheum. 2005 Aug;52(8):2386-95 19155294 - Cancer Res. 2009 Feb 1;69(3):1109-16 3313057 - Nature. 1987 Nov 5-11;330(6143):80-2 8400238 - Blood. 1993 Sep 15;82(6):1875-83 12529407 - Mol Cell Biol. 2003 Feb;23(3):1034-43 10536818 - J Am Soc Mass Spectrom. 1999 Nov;10(11):1124-30 10085090 - J Biol Chem. 1999 Mar 26;274(13):8561-9 17068066 - Ann Rheum Dis. 2007 Mar;66(3):334-40 15831077 - Crit Rev Eukaryot Gene Expr. 2005;15(1):29-48 8179823 - DNA Cell Biol. 1994 Feb;13(2):183-92 17050004 - Biochim Biophys Acta. 2006 Nov;1763(11):1298-306 8592003 - J Cell Physiol. 1996 Feb;166(2):427-37 17530716 - Arthritis Rheum. 2007 Jun;56(6):1880-93 19035520 - Arthritis Rheum. 2008 Dec;58(12):3776-87 18374667 - Biochim Biophys Acta. 2008 May;1779(5):330-40 16690079 - J Mol Biol. 2006 Jun 16;359(4):961-72 16859525 - Arthritis Res Ther. 2006;8(4):R124 12592548 - Eur Spine J. 2003 Feb;12(1):57-65 17968891 - Arthritis Rheum. 2007 Nov;56(11):3675-84 14597310 - Methods. 2003 Dec;31(4):265-73 10606357 - J Rheumatol. 1999 Dec;26(12):2523-8 RK Davidson (2752_CR32) 2006; 8 CB Little (2752_CR16) 2007; 117 N Leukert (2752_CR38) 2006; 359 J Wu (2752_CR33) 2007; 56 T Vogl (2752_CR19) 2006; 1763 H Zreiqat (2752_CR13) 2007; 38 AB Campos-Xavier (2752_CR26) 2009; 84 PL van Lent (2752_CR43) 2007; 66 PL van Lent (2752_CR12) 2008; 67 GK Smyth (2752_CR23) 2003; 31 RK Kumar (2752_CR36) 2001; 70 MC Farach-Carson (2752_CR42) 2005; 15 CJ Cornish (2752_CR2) 1996; 166 MM Smith (2752_CR21) 2008; 58 T Vogl (2752_CR11) 2007; 13 Y Benjamini (2752_CR30) 1995; 57 R Wilson (2752_CR37) 2008; 58 SA Bustin (2752_CR22) 2002; 29 KJ Greenlee (2752_CR31) 2006; 177 MP Manitz (2752_CR6) 2003; 23 DL Cecil (2752_CR5) 2005; 175 J Roth (2752_CR29) 1993; 82 MJ Raftery (2752_CR4) 1999; 15 JM Wettenhall (2752_CR24) 2004; 20 PL van Lent (2752_CR9) 2008; 58 D Belluoccio (2752_CR25) 2008; 1779 SE Iismaa (2752_CR28) 1994; 13 J Roth (2752_CR8) 1992; 186 CB Little (2752_CR17) 2005; 52 MJ Robinson (2752_CR40) 2002; 277 P Ehlermann (2752_CR39) 2006; 5 T Vogl (2752_CR1) 2004; 104 CA Harrison (2752_CR3) 1999; 274 J Melrose (2752_CR18) 2003; 12 M Kobayashi (2752_CR15) 2005; 52 DM Maru (2752_CR35) 2009; 174 JH Lee (2752_CR44) 2005; 52 HE Barksby (2752_CR14) 2006; 54 J Vandesompele (2752_CR27) 2002; 3 K Bobacz (2752_CR41) 2007; 56 P Youssef (2752_CR10) 1999; 26 T Vogl (2752_CR20) 1999; 10 Z Li (2752_CR34) 2009; 69 K Odink (2752_CR7) 1987; 330 |
References_xml | – volume: 56 start-page: 3675 year: 2007 ident: 2752_CR33 publication-title: Arthritis Rheum doi: 10.1002/art.22876 contributor: fullname: J Wu – volume: 20 start-page: 3705 year: 2004 ident: 2752_CR24 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bth449 contributor: fullname: JM Wettenhall – volume: 1779 start-page: 330 issue: 5 year: 2008 ident: 2752_CR25 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbagrm.2008.02.010 contributor: fullname: D Belluoccio – volume: 84 start-page: 760 year: 2009 ident: 2752_CR26 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2009.05.002 contributor: fullname: AB Campos-Xavier – volume: 15 start-page: 228 year: 1999 ident: 2752_CR4 publication-title: Protein Expr Purif doi: 10.1006/prep.1998.1015 contributor: fullname: MJ Raftery – volume: 274 start-page: 8561 year: 1999 ident: 2752_CR3 publication-title: J Biol Chem doi: 10.1074/jbc.274.13.8561 contributor: fullname: CA Harrison – volume: 70 start-page: 59 year: 2001 ident: 2752_CR36 publication-title: J Leukoc Biol doi: 10.1189/jlb.70.1.59 contributor: fullname: RK Kumar – volume: 166 start-page: 427 year: 1996 ident: 2752_CR2 publication-title: J Cell Physiol doi: 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6 contributor: fullname: CJ Cornish – volume: 58 start-page: 1055 year: 2008 ident: 2752_CR21 publication-title: Arthritis Rheum doi: 10.1002/art.23388 contributor: fullname: MM Smith – volume: 8 start-page: R124 year: 2006 ident: 2752_CR32 publication-title: Arthritis Res Ther doi: 10.1186/ar2013 contributor: fullname: RK Davidson – volume: 29 start-page: 23 year: 2002 ident: 2752_CR22 publication-title: J Mol Endocrinol doi: 10.1677/jme.0.0290023 contributor: fullname: SA Bustin – volume: 56 start-page: 1880 year: 2007 ident: 2752_CR41 publication-title: Arthritis Rheum doi: 10.1002/art.22637 contributor: fullname: K Bobacz – volume: 5 start-page: 6 year: 2006 ident: 2752_CR39 publication-title: Cardiovasc Diabetol doi: 10.1186/1475-2840-5-6 contributor: fullname: P Ehlermann – volume: 175 start-page: 8296 year: 2005 ident: 2752_CR5 publication-title: J Immunol doi: 10.4049/jimmunol.175.12.8296 contributor: fullname: DL Cecil – volume: 12 start-page: 57 year: 2003 ident: 2752_CR18 publication-title: Eur Spine J doi: 10.1007/s00586-002-0434-6 contributor: fullname: J Melrose – volume: 330 start-page: 80 year: 1987 ident: 2752_CR7 publication-title: Nature doi: 10.1038/330080a0 contributor: fullname: K Odink – volume: 10 start-page: 1124 year: 1999 ident: 2752_CR20 publication-title: J Am Soc Mass Spectrom doi: 10.1016/S1044-0305(99)00085-9 contributor: fullname: T Vogl – volume: 13 start-page: 1042 year: 2007 ident: 2752_CR11 publication-title: Nat Med doi: 10.1038/nm1638 contributor: fullname: T Vogl – volume: 117 start-page: 1627 year: 2007 ident: 2752_CR16 publication-title: J Clin Invest doi: 10.1172/JCI30765 contributor: fullname: CB Little – volume: 15 start-page: 29 year: 2005 ident: 2752_CR42 publication-title: Crit Rev Eukaryot Gene Expr doi: 10.1615/CritRevEukaryotGeneExpr.v15.i1.30 contributor: fullname: MC Farach-Carson – volume: 58 start-page: 3776 year: 2008 ident: 2752_CR9 publication-title: Arthritis Rheum doi: 10.1002/art.24074 contributor: fullname: PL van Lent – volume: 104 start-page: 4260 year: 2004 ident: 2752_CR1 publication-title: Blood doi: 10.1182/blood-2004-02-0446 contributor: fullname: T Vogl – volume: 52 start-page: 128 year: 2005 ident: 2752_CR15 publication-title: Arthritis Rheum doi: 10.1002/art.20776 contributor: fullname: M Kobayashi – volume: 54 start-page: 540 year: 2006 ident: 2752_CR14 publication-title: Arthritis Rheum doi: 10.1002/art.21574 contributor: fullname: HE Barksby – volume: 174 start-page: 1940 year: 2009 ident: 2752_CR35 publication-title: Am J Pathol doi: 10.2353/ajpath.2009.080718 contributor: fullname: DM Maru – volume: 13 start-page: 183 year: 1994 ident: 2752_CR28 publication-title: DNA Cell Biol doi: 10.1089/dna.1994.13.183 contributor: fullname: SE Iismaa – volume: 1763 start-page: 1298 year: 2006 ident: 2752_CR19 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamcr.2006.08.028 contributor: fullname: T Vogl – volume: 26 start-page: 2523 year: 1999 ident: 2752_CR10 publication-title: J Rheumatol contributor: fullname: P Youssef – volume: 52 start-page: 1461 year: 2005 ident: 2752_CR17 publication-title: Arthritis Rheum doi: 10.1002/art.21022 contributor: fullname: CB Little – volume: 177 start-page: 7312 year: 2006 ident: 2752_CR31 publication-title: J Immunol doi: 10.4049/jimmunol.177.10.7312 contributor: fullname: KJ Greenlee – volume: 67 start-page: 1750 year: 2008 ident: 2752_CR12 publication-title: Ann Rheum Dis doi: 10.1136/ard.2007.077800 contributor: fullname: PL van Lent – volume: 82 start-page: 1875 year: 1993 ident: 2752_CR29 publication-title: Blood doi: 10.1182/blood.V82.6.1875.1875 contributor: fullname: J Roth – volume: 359 start-page: 961 year: 2006 ident: 2752_CR38 publication-title: J Mol Biol doi: 10.1016/j.jmb.2006.04.009 contributor: fullname: N Leukert – volume: 186 start-page: 304 year: 1992 ident: 2752_CR8 publication-title: Immunobiology doi: 10.1016/S0171-2985(11)80259-7 contributor: fullname: J Roth – volume: 66 start-page: 334 year: 2007 ident: 2752_CR43 publication-title: Ann Rheum Dis doi: 10.1136/ard.2006.057471 contributor: fullname: PL van Lent – volume: 69 start-page: 1109 year: 2009 ident: 2752_CR34 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-3381 contributor: fullname: Z Li – volume: 38 start-page: 381 year: 2007 ident: 2752_CR13 publication-title: J Mol Histol doi: 10.1007/s10735-007-9117-2 contributor: fullname: H Zreiqat – volume: 52 start-page: 2386 year: 2005 ident: 2752_CR44 publication-title: Arthritis Rheum doi: 10.1002/art.21215 contributor: fullname: JH Lee – volume: 58 start-page: 3120 year: 2008 ident: 2752_CR37 publication-title: Arthritis Rheum doi: 10.1002/art.23789 contributor: fullname: R Wilson – volume: 31 start-page: 265 year: 2003 ident: 2752_CR23 publication-title: Methods doi: 10.1016/S1046-2023(03)00155-5 contributor: fullname: GK Smyth – volume: 23 start-page: 1034 year: 2003 ident: 2752_CR6 publication-title: Mol Cell Biol doi: 10.1128/MCB.23.3.1034-1043.2003 contributor: fullname: MP Manitz – volume: 3 start-page: RESEARCH0034 year: 2002 ident: 2752_CR27 publication-title: Genome Biol doi: 10.1186/gb-2002-3-7-research0034 contributor: fullname: J Vandesompele – volume: 277 start-page: 3658 year: 2002 ident: 2752_CR40 publication-title: J Biol Chem doi: 10.1074/jbc.M102950200 contributor: fullname: MJ Robinson – volume: 57 start-page: 289 year: 1995 ident: 2752_CR30 publication-title: Journal of the Royal Statistical Society Series doi: 10.1111/j.2517-6161.1995.tb02031.x contributor: fullname: Y Benjamini |
SSID | ssj0022924 |
Score | 2.2672288 |
Snippet | The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA) as opposed... Introduction The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA)... INTRODUCTIONThe objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis (OA)... INTRODUCTION: The objective was to evaluate the changes in S100A8 S100A9, and their complex (S100A8/S100A9) in cartilage during the onset of osteoarthritis... |
SourceID | pubmedcentral biomedcentral proquest gale crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | R16 |
SubjectTerms | Animals Arthritis, Experimental - genetics Arthritis, Experimental - metabolism Arthritis, Experimental - pathology Calcium-binding proteins Calgranulin A Calgranulin B - biosynthesis Cartilage - metabolism Cartilage - pathology Cartilage cells Chondrocytes - metabolism Development and progression Gene Expression Gene Expression Profiling Gene Expression Regulation Genetic aspects Male Mice Mice, Inbred C57BL Oligonucleotide Array Sequence Analysis Osteoarthritis Osteoarthritis - genetics Osteoarthritis - metabolism Osteoarthritis - pathology Physiological aspects Research article Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - analysis S100 Proteins - biosynthesis |
SummonAdditionalLinks | – databaseName: BiomedCentral dbid: RBZ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED_mBPFF_LY6NQ-CT8UmTb8epziGMB_UwfClJE3CBtLJ3P5_L21XF_HJt8IlkNwlufs1l98B3IRcslgz7qtIcAQoifRFlEkffWGm0OVIWfHMjp7j4Zg_TaJJB8jfN_g0je_EgiGk2IJtBAqhhVcv9-8tpGJZXbaWIxZC18mb6kE__X69Y_9w3M_vQ3jDC7kZkhsuZ7APe02sSPq1cQ-go8tD2Bk1t-FHELzSIOinRJSKVJ8ZmZVkk7Of2Cccc1wd04q76BjGg8e3h6HfVEDwJSKJpa-KlIWKW9AihQoSTUOdFEVoCkMNxdhDGWHSJGNFrAVijZQrGVt6YUOZNFyEJ9At56U-A4I4SKHvlhSNxsNUCkq1VCoxLAtYISMPmKOo_LNmu8gt_7Qrwa2Q19r14HqtzbZ9hSrSuG1xa5Wc2-2CnQvRZP3joCzxVN5njCKmwnPDg57TEpd54YjJ2ky5FdncsFLPV1-5rToZREHMPDitrdaOxV71RzgMDxLHns7kXEk5m1Yk24gkI4wVz_-jlgvYrZMM7J-aHnSXi5W-xNhlKa-q5fsNRX7uyg priority: 500 providerName: BioMedCentral |
Title | S100A8 and S100A9 in experimental osteoarthritis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20105291 https://search.proquest.com/docview/733105062 http://dx.doi.org/10.1186/ar2917 https://pubmed.ncbi.nlm.nih.gov/PMC2875644 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB60B_Eivo1WzUHwlDa72byOsViKUBG1IF7CvoIFTUXr_3d2k5SuRy8hsLth399-m5lvAK4iJmiiKQtUzBkSlFQEPM5FgFiYK4QcIazO7PQ-mczY3Uv8sgFx5wtjjfalmA_q949BPX-ztpWfH3LY2YkNH6YjPOXHiOPDTdhE-O0oesuyaN5EsmVIjxBNWRtQiGQJfoMiOzH6vyYuJDW6nI6X-7sDTn-36DWMcu0n1wBpvAs77UnSL5oa78GGrvdha9r-Kz-A8ImEYZH5vFa-fc39ee2vK_r7xsFjgU1-s8pGhzAb3z6PJkEbHyEQyDOWgZIZjRQzlEZwFaaaRDqVMqpkRSqCJxNV8SpLcyoTzZGJZEyJxIgPV4SKivHoCHr1otYn4CNLUojsguCQsigTnBAtlEormodUitgD6nRU-dloYZRGndpNwYVSNh3twWXXm6v8lnNkySrHtenk0iwmLCx56xOAlTKyVGVBKUHGhbuKB30nJy4C6ST73TCVJslYjtV68fNdmpiUYRwm1IPjZtRWdelmgQepM55O49wUnJFWgrudgaf_LnkG240dgrnM6UNv-fWjz_F4sxQX9loAn483rxd2auNzRotfCuH9Jw |
link.rule.ids | 108,230,314,727,780,784,864,885,24937,27924,27925,53791,53793,75811,75812 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7MCeqLeLfe1gfBp7omTW-PQxxTtyE4wbeSW3HguqHb__ekl7H46FshSUnOSfLla0--A3AbMEEjTZmnQs6QoMTC42EqPMTCVCHkCFHqzI7G0eCdPX-EHy0Im7swZdC-FNP74mt2X0w_y9jKxUx2mzix7uvoAU_5IeJ4dwu2wyBOSUPSa55F0yqXLUOChHjK6pRCJInwLRT5iVEANpkhqVHmtO65f1nw9HeT3kApO4JyA5L6B7BfnyXdXtXnQ2jp4gh2RvXf8mPw34jv9xKXF8otH1N3Wribmv6uueIxx0F_ltpGJ_Def5w8DLw6Q4InkGksPSUTGihmSI3gyo81CXQsZZDLnOQEzyYq53kSp1RGmiMXSZgSkZEfzgkVOePBKbSLeaHPwUWepBDbBUGnsiARnBAtlIpzmvpUitABahkqW1RqGJnRp7ZLcKlklaEd6DTWXNcvWUcSrWvcGSNnZjlhY8nrWwHYKSNMlfUoJci5cF9x4MqqictAWsVu46bMFJnYsULPVz-ZyUrph35EHTirvLbuSzMLHIgtf1qDs0twTpYi3PUcvPh3yw7sDiajYTZ8Gr9cwl4VlWA-7VxBe_m90td42FmKm3Jq_wKnr_2P |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xSIgLYiesOSBxCo0dZztWQMXWqhIgcYu8qpXatILy_4yzVDVHbpHGjuyZsccvGb8BuI6YoImmLFAxZwhQUhHwOBcBxsJcYcgRouKZ7Q-Sxw_2_Bl_rpT6qpL2pRjflpPpbTkeVbmV86nstHlinWH_Dk_5McbxzlyZzjpsxhE6WQvUG6xF87qeLUOQhDGVNWWFSJbgmyhiFMsCbKtDUsvO6dx1nzgh6u9GvRKp3CzKlbDU24Wd5jzpd-tx78GaLvdhq9_8MT-A8I2EYTfzean86jH3x6W_yuvv22seM5z4qOI3OoSP3sP73WPQVEkIBKKNRaBkRiPFLLARXIWpJpFOpYyMNMQQPJ8ow02W5lQmmiMeyZgSiaUgNoQKw3h0BBvlrNQn4CNWUhjfBUHDsigTnBAtlEoNzUMqRewBdRRVzGtGjMJyVLsSXC5FrWgPrlptLttXyCNLli1urJILu6Sws-TNzQAclCWnKrqUEsRduLd4cO60xKUgHbHfmqmwIps_VurZz3dhK1OGcZhQD45rqy3H0nqBB6ljT2dyrgT9siLibvzw9N89r2BreN8rXp8GL2ewXScm2K8757Cx-PrRF3jeWYjLyrN_AU1q_qI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=S100A8+and+S100A9+in+experimental+osteoarthritis&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Zreiqat%2C+Hala&rft.au=Belluoccio%2C+Daniele&rft.au=Smith%2C+Margaret+M&rft.au=Wilson%2C+Richard&rft.date=2010-01-01&rft.pub=BioMed+Central+Ltd&rft.issn=1478-6354&rft.volume=12&rft.spage=R16&rft_id=info:doi/10.1186%2Far2917&rft.externalDocID=A221626578 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6354&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6354&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6354&client=summon |